Filing Details

Accession Number:
0000875320-11-000018
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-24 16:33:13
Reporting Period:
2011-02-23
Filing Date:
2011-02-24
Accepted Time:
2011-02-24 16:33:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406338 Amit Sachdev C/O Vertex Pharmaceuticals Incorporated
130 Waverly Street
Cambridge MA 02139
Svp, Corp Affairs & Pub Policy No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-23 23,828 $18.93 67,954 No 4 M Direct
Common Stock Disposition 2011-02-23 11,914 $43.60 56,040 No 4 S Direct
Common Stock Disposition 2011-02-23 11,914 $44.00 44,126 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2011-02-23 23,828 $0.00 23,828 $18.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,446 2008-05-15 2018-02-06 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 410 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
  2. Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/07/2008, except that the first quarterly vesting occurred on May 15, 2008.